Travere Therapeutics TVTX reported its Q4 earnings results on Thursday, February 24, 2022 at 04:01 PM.
Here's what investors need to know about the announcement.
Earnings
Travere Therapeutics beat estimated earnings by 15.28%, reporting an EPS of $-0.61 versus an estimate of $-0.72.
Revenue was up $6.27 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.41 which was followed by a 8.35% increase in the share price the next day.
Here's a look at Travere Therapeutics's past performance:
Quarter | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
---|---|---|---|---|
EPS Estimate | -0.54 | -0.68 | -0.39 | -0.47 |
EPS Actual | -0.13 | -0.39 | -0.55 | -0.48 |
Revenue Estimate | 60.93M | 50.33M | 50.09M | 51.66M |
Revenue Actual | 68.22M | 54.62M | 47.41M | 50.98M |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.